Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung

Jill M. Siegfried; James D. Luketich; Laura P. Stabile; Neil Christie; Stephanie R. Land

doi:10.1378/chest.125.5_suppl.116S

Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung

Jill M. Siegfried, James D. Luketich, Laura P. Stabile, Neil Christie, Stephanie R. Land

Pharmacology

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	116S-119S
Journal	CHEST
Volume	125
Issue number	5 SUPPL.
DOIs	https://doi.org/10.1378/chest.125.5_suppl.116S
State	Published - May 2004

Bibliographical note

Funding Information:
This research was supported by grants RO1 CA 79882 and P50 CA090440 (Specialized Program of Research Excellence in Lung Cancer) awarded to Dr. Siegfried from the National Cancer Institute. Dr. Stabile was supported by a fellowship from the American Lung Association.

Publisher link

10.1378/chest.125.5_suppl.116S

Find It

Find It at U of M Libraries

Cite this

@article{92426e8e7b1040ffb1daabe5753d64eb,

title = "Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung",

author = "Siegfried, {Jill M.} and Luketich, {James D.} and Stabile, {Laura P.} and Neil Christie and Land, {Stephanie R.}",

note = "Funding Information: This research was supported by grants RO1 CA 79882 and P50 CA090440 (Specialized Program of Research Excellence in Lung Cancer) awarded to Dr. Siegfried from the National Cancer Institute. Dr. Stabile was supported by a fellowship from the American Lung Association. ",

year = "2004",

month = may,

doi = "10.1378/chest.125.5_suppl.116S",

language = "English (US)",

volume = "125",

pages = "116S--119S",

journal = "Diseases of the chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "5 SUPPL.",

}

TY - JOUR

T1 - Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung

AU - Siegfried, Jill M.

AU - Luketich, James D.

AU - Stabile, Laura P.

AU - Christie, Neil

AU - Land, Stephanie R.

N1 - Funding Information: This research was supported by grants RO1 CA 79882 and P50 CA090440 (Specialized Program of Research Excellence in Lung Cancer) awarded to Dr. Siegfried from the National Cancer Institute. Dr. Stabile was supported by a fellowship from the American Lung Association.

PY - 2004/5

Y1 - 2004/5

UR - http://www.scopus.com/inward/record.url?scp=2442528239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442528239&partnerID=8YFLogxK

U2 - 10.1378/chest.125.5_suppl.116S

DO - 10.1378/chest.125.5_suppl.116S

M3 - Article

C2 - 15136456

AN - SCOPUS:2442528239

SN - 0012-3692

VL - 125

SP - 116S-119S

JO - Diseases of the chest

JF - Diseases of the chest

IS - 5 SUPPL.

ER -

Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung

Bibliographical note

Publisher link

Find It

Other files and links

Cite this